查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1679391

美國傷口清洗市場規模、佔有率、趨勢分析報告：按產品、產品形式、應用、最終用途和細分市場預測，2025-2030 年

U.S. Wound Wash Market Size, Share & Trends Analysis Report By Product (Antiseptic, Saline Solution), By Product Form (Solutions, Sprays, Wipes), By Application (Acute Wounds, Chronic Wounds), By End-use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

美國傷口清洗市場的成長與趨勢

根據Grand View Research, Inc.的最新報告，美國傷口清洗市場規模預計到2030年將達到4.2081億美元，預測期內的複合年成長率為5.56%。

由於手術和創傷病例的增加以及糖尿病潰瘍和壓瘡等慢性傷口的盛行率不斷上升，美國的傷口清洗市場正在經歷顯著成長。隨著抗菌劑、生物膜破壞溶液和自動灌溉系統的進步，傳統的傷口清洗方法已經發生了變化，使得創傷護理更加有效和高效。向先進抗菌解決方案的轉變是推動傷口清洗市場發展的最重要因素之一。

美國傷口清洗市場的新產品發布和 FDA核准正在透過刺激創新、提高安全標準和改善臨床結果來推動傷口清洗和手術清洗的重大進步。 2023 年 6 月，Armis Biopharma 的 VeriCyn 傷口清洗液獲得 FDA 的 510(k) 批准，標誌著創傷護理解決方案取得了重要進展。此項核準確保了該產品符合傷口碎片清除的安全性和有效性標準，增強了其可信度和廣泛採用性。此次核准也反映了傷口和外科清洗產品的持續技術進步，促進了創新抗菌和生物活性配方的開發。隨著對安全有效的傷口清洗解決方案的需求不斷增加，此類 FDA核准將有助於推動市場擴張、改善患者治療效果並鼓勵美國傷口清洗市場的進一步創新。

此外，軍事部門和工業相關人員透過戰略聯盟和夥伴關係增加的投資也對美國創傷護理市場產生了重大影響。這些因素共同推動了創新、增強了產品開發、擴大了市場範圍並支持了成長。例如，2024年1月，美國授予總部位於明尼蘇達州的3M公司一份價值3420萬美元的契約，用於開發針對創傷​​、感染疾病和相關癒合過程的醫療解決方案。這些舉措旨在加強軍事和民事環境中對爆炸、燒燙傷和槍傷等急性創傷的照護。

美國傷口清洗市場報告重點

  • 根據產品來看，防腐劑部門貢獻了最大的收入佔有率，因為它能有效預防感染，這是創傷護理中一個主要關注點。
  • 根據產品形式，解決方案部分由於其多功能性、易用性以及清洗各種傷口的能力而貢獻了最大的收益佔有率。
  • 根據應用，急性傷口部分貢獻了最大的收入佔有率。急性傷口更為常見，通常需要立即護理，從而推動了對傷口清洗產品的需求。
  • 根據最終用途，醫院佔據市場主導地位，佔據最大的收入佔有率。醫院是傷口清洗劑的最大消費者。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國傷口清洗市場變數、趨勢與範圍

  • 市場體系展望
    • 補貼市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國傷口清洗市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析

第4章美國傷口清洗市場：按產品分類的估計和趨勢分析

  • 細分儀表板
  • 美國傷口清洗市場產品變化分析
  • 2018-2030 年美國傷口清洗產品市場規模及趨勢分析（依產品）
  • 防腐劑
    • 優碘
    • 洛赫西定
    • 聚六聚醯胺（PHMB）
    • 其他
  • 生理食鹽水
  • 灌溉解決方案
  • 脈衝清洗系統
    • 一次性的
    • 可重複使用的
    • 半一次性
  • 其他

第5章美國傷口清洗市場（按產品類型、估計和趨勢分析）

  • 細分儀表板
  • 美國傷口清洗市場產品形態變化分析
  • 2018-2030 年美國傷口清洗產品市場規模及趨勢分析（依產品類型）
  • 解決方案
  • 噴
  • 擦拭巾
  • 其他

第6章美國傷口清洗市場：按應用的估計和趨勢分析

  • 細分儀表板
  • 美國傷口清洗市場應用趨勢分析
  • 2018-2030年美國傷口清洗市場規模及應用趨勢分析
  • 急性傷口
    • 外科性創傷與創傷傷口
    • 燒燙傷和撕裂傷
  • 慢性傷口
    • 糖尿病足潰瘍
    • 壓瘡
    • 靜脈性腿部潰瘍
    • 其他慢性傷口

第7章美國傷口清洗市場：最終用途、估計與趨勢分析

  • 細分儀表板
  • 美國傷口清洗市場的最終用途趨勢分析
  • 2018-2030 年美國傷口清洗產品市場規模及最終用途趨勢分析
  • 醫院
  • 專科診所
  • 門診手術中心
  • 軍事和國防
  • 其他

第8章競爭格局

  • 市場參與企業分類
  • 主要企業簡介
    • Atlantis Consumer Healthcare Inc.
    • Medline Industries, LP
    • B. Braun SE
    • Johnson & Johnson Consumer Inc.（Johnson & Johnson）
    • Zimmer Biomet
    • Urgo Medical North America（URGO Group）
    • Coloplast Corp（Coloplast Group）
    • Molnlycke Health Care AB
    • Cardinal Health
    • Armis Biopharma
    • Bravida Medical
    • Irrimax Corporation
    • BD
    • Sanara MedTech Inc.
    • Pure& Clean
    • Innovacyn, Inc.
Product Code: GVR-4-68040-524-8

U.S. Wound Wash Market Growth & Trends:

The U.S. wound wash market size is anticipated to reach USD 420.81 million by 2030 and is anticipated to expand at a CAGR of 5.56% during the forecast period, according to a new report by Grand View Research, Inc. The U.S. wound wash market is experiencing significant growth due to the increasing number of surgical procedures, trauma cases, and the rising prevalence of chronic wounds such as diabetic ulcers and pressure sores. Traditional wound cleansing methods have evolved with advancements in antimicrobial agents, biofilm-disrupting solutions, and automated irrigation systems, making wound care more effective and efficient. The shift toward advanced antimicrobial solutions is one of the most essential factors driving the wound wash market.

New product launches and FDA approvals in the U.S. wound wash market drive significant wound and surgical wash advancements by promoting innovation, enhancing safety standards, and improving clinical outcomes. In June 2023, VeriCyn Wound Wash from Armis Biopharma obtained 510(k) clearance from the FDA, marking a significant advancement in wound care solutions. This regulatory approval enhances the credibility and adoption of the product, ensuring it meets safety and efficacy standards for wound debris removal. The approval also reflects ongoing technological advancements in wound and surgical washes, promoting the development of innovative, antimicrobial, and bioactive formulations. As demand for safe and effective wound cleansing solutions grows, such FDA approvals drive market expansion, improve patient outcomes, and encourage further innovations in the U.S. wound wash market.

Furthermore, the U.S. wound care market is significantly influenced by increased investments from military sectors and industry players through strategic collaborations and partnerships. These factors collectively drive innovation, enhance product development, and expand market reach, propelling growth. For instance, in January 2024, the U.S. Army has awarded Minnesota's 3M Company a USD 34.2-million contract to develop medical solutions for traumatic wounds, infection, and associated healing processes. These initiatives aim to enhance care for acute trauma cases such as blasts, burns, and gunshot wounds in military and civilian settings.

U.S. Wound Wash Market Report Highlights:

  • Based on product, the antiseptic segment dominate the market with the largest revenue share owing to their effectiveness in preventing infection, a primary concern in wound care.
  • Based on product form, the solutions segment dominate the market with the largest revenue share owing to their versatility, ease of use, and ability to clean a wide range of wounds.
  • Based on application, the acute wound segment dominate the market with the largest revenue share. Acute wounds, being more common and often requiring immediate care, drive the demand for wound wash products.
  • Based on end-use, the hospitals dominated the market with the largest revenue share owing to their high volume of patients and diverse wound care needs. Hospitals are the largest consumers of wound wash products.

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Wound Wash Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing number of surgical procedures
      • 3.2.1.2. Rising prevalence of chronic wounds
      • 3.2.1.3. Advancements in wound and surgical washes
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulatory approvals & compliance costs
      • 3.2.2.2. Adverse events and complications associated with the use of wound wash
  • 3.3. U.S. Wound Wash Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Wound Wash Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Wound Wash Market Product Movement Analysis
  • 4.3. U.S. Wound Wash Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Antiseptic
    • 4.4.1. Antiseptic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Povidone Iodine
      • 4.4.2.1. Povidone Iodine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Chlorhexidine
      • 4.4.3.1. Chlorhexidine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Polyhexanide (PHMB)
      • 4.4.4.1. Polyhexanide (PHMB) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Saline Solution
    • 4.5.1. Saline Solution Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Irrigation Solution
    • 4.6.1. Irrigation Solution Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Pulsed Lavage Systems
    • 4.7.1. Pulsed Lavage Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.2. Disposable
      • 4.7.2.1. Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.3. Reusable
      • 4.7.3.1. Reusable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.4. Semi Disposable
      • 4.7.4.1. Semi Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Wound Wash Market: Product Form Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Wound Wash Market Product Form Movement Analysis
  • 5.3. U.S. Wound Wash Market Size & Trend Analysis, by Product Form, 2018 to 2030 (USD Million)
  • 5.4. Solutions
    • 5.4.1. Solutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Sprays
    • 5.5.1. Sprays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Wipes
    • 5.6.1. Wipes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Wound Wash Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Wound Wash Market Application Movement Analysis
  • 6.3. U.S. Wound Wash Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Acute Wounds
    • 6.4.1. Acute Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Surgical & Traumatic Wounds
      • 6.4.2.1. Surgical & Traumatic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Burns & Lacerations
      • 6.4.3.1. Burns & Lacerations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Chronic Wounds
    • 6.5.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Diabetic Foot Ulcers
      • 6.5.2.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Pressure Ulcers
      • 6.5.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Venous Leg Ulcers
      • 6.5.4.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Other Chronic Wounds
      • 6.5.5.1. Other Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Wound Wash Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Wound Wash Market End Use Movement Analysis
  • 7.3. U.S. Wound Wash Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Specialty Clinics
    • 7.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Ambulatory Surgery Centers
    • 7.6.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Military & Defense
    • 7.7.1. Military & Defense Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Others
    • 7.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Atlantis Consumer Healthcare Inc.
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Service Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Medline Industries, LP
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Service Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. B. Braun SE
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Service Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Johnson & Johnson Consumer Inc. (Johnson & Johnson)
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Service Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Zimmer Biomet
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Service Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Urgo Medical North America (URGO Group)
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Service Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Coloplast Corp (Coloplast Group)
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Service Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Molnlycke Health Care AB
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Service Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Cardinal Health
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Service Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Armis Biopharma
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Service Benchmarking
      • 8.2.10.4. Strategic Initiatives
    • 8.2.11. Bravida Medical
      • 8.2.11.1. Company Overview
      • 8.2.11.2. Financial Performance
      • 8.2.11.3. Service Benchmarking
      • 8.2.11.4. Strategic Initiatives
    • 8.2.12. Irrimax Corporation
      • 8.2.12.1. Company Overview
      • 8.2.12.2. Financial Performance
      • 8.2.12.3. Service Benchmarking
      • 8.2.12.4. Strategic Initiatives
    • 8.2.13. BD
      • 8.2.13.1. Company Overview
      • 8.2.13.2. Financial Performance
      • 8.2.13.3. Service Benchmarking
      • 8.2.13.4. Strategic Initiatives
    • 8.2.14. Sanara MedTech Inc.
      • 8.2.14.1. Company Overview
      • 8.2.14.2. Financial Performance
      • 8.2.14.3. Service Benchmarking
      • 8.2.14.4. Strategic Initiatives
    • 8.2.15. Pure&Clean
      • 8.2.15.1. Company Overview
      • 8.2.15.2. Financial Performance
      • 8.2.15.3. Service Benchmarking
      • 8.2.15.4. Strategic Initiatives
    • 8.2.16. Innovacyn, Inc.
      • 8.2.16.1. Company Overview
      • 8.2.16.2. Financial Performance
      • 8.2.16.3. Service Benchmarking
      • 8.2.16.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. U.S. Wound Wash Market, By Product, 2018 - 2030 (USD Million)
  • Table 4. U.S. Wound Wash Market, By Product Form, 2018 - 2030 (USD Million)
  • Table 5. U.S. Wound Wash Market, By Application, 2018 - 2030 (USD Million)
  • Table 6. U.S. Wound Wash Market, By End Use, 2018 - 2030 (USD Million)
  • Table 7. Participant's Overview
  • Table 8. Financial Performance
  • Table 9. Product Benchmarking
  • Table 10. Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Wound Wash Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 U.S. Wound Wash Market, for Antiseptic, 2018 - 2030 (USD Million)
  • Fig. 15 U.S. Wound Wash Market, for Povidone Iodine, 2018 - 2030 (USD Million)
  • Fig. 16 U.S. Wound Wash Market, for Chlorhexidine, 2018 - 2030 (USD Million)
  • Fig. 17 U.S. Wound Wash Market, for Polyhexanide (PHMB), 2018 - 2030 (USD Million)
  • Fig. 18 U.S. Wound Wash Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 19 U.S. Wound Wash Market, for Saline Solution, 2018 - 2030 (USD Million)
  • Fig. 20 U.S. Wound Wash Market, for Irrigation Solution, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. Wound Wash Market, for Pulsed Lavage Systems, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. Wound Wash Market, for Disposable, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Wound Wash Market, for Reusable, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. Wound Wash Market, for Semi Disposable, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. Wound Wash Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. Wound Wash Market, for Solutions, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Wound Wash Market, for Sprays, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. Wound Wash Market, for Wipes, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Wound Wash Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. Wound Wash Market, for Acute Wounds, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Wound Wash Market, for Surgical & Traumatic Wounds, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Wound Wash Market, for Burns & Lacerations, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Wound Wash Market, for Chronic Wounds, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. Wound Wash Market, for Diabetic Foot Ulcers, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Wound Wash Market, for Pressure Ulcers, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Wound Wash Market, for Venous Leg Ulcers, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Wound Wash Market, for Other Chronic Wounds, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Wound Wash Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Wound Wash Market, for Specialty Clinics, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Wound Wash Market, for Ambulatory Surgery Centers, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Wound Wash Market, for Military & Defense, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. Wound Wash Market, for Others, 2018 - 2030 (USD Million)